About MTEK Sciences
MTEK Sciences is a Healthcare company based in Vancouver (Canada) founded in 2017 by Edward Mills, and was acquired by Cytel in November 2019. Software is developed for clinical study design and analysis. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials.
Company details
MTEK Sciences a developer of software for clinical study designs and biostatistical methods. The solutions developed are Clinical Trial Simulator, synthetic Control Arm Application, and Dynamic Treatment Decision Model.
- Headquarters Vancouver, Canada
- Founders Edward Mills
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website mteksciences.com
- Social LinkedIn X
- Acquired by Cytel (Nov 2019)
Investors in MTEK Sciences
MTEK Sciences has secured backing from 1 investor. Prominent investors backing the company include Cytel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Data analysis and statistical solutions are provided for life sciences. | 1987 | cytel.com | Cambridge, United States |
Investor details for MTEK Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MTEK Sciences
1 people are tracked at MTEK Sciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Edward Mills | Co-Founder | Leadership |
Complete people profiles for MTEK Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MTEK Sciences
2 dated milestones of MTEK Sciences across 2 years, from founding to its latest funding, stage changes and deals.
- Founded MTEK Sciences is founded.
- Exit Acquired by Cytel.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mtek Sciences
Complete news archive for MTEK Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MTEK Sciences
MTEK Sciences was founded in 2017.
MTEK Sciences is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
MTEK Sciences a developer of software for clinical study designs and biostatistical methods. The solutions developed are Clinical Trial Simulator, synthetic Control Arm Application, and Dynamic Treatment Decision Model.
MTEK Sciences has 1 investor. Key investors include Cytel.
Yes. MTEK Sciences was acquired by Cytel in November 2019.